Larson Financial Group LLC Puma Biotechnology, Inc. Transaction History

Larson Financial Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 14, 2021	SELL	$7.78 - $12.13 $1,983 - $3,093	-255 Closed	0 $0
Q3 2020 Oct 08, 2020	BUY	$9.5 - $11.14 $2,422 - $2,840	255 New	255 $3,000
Q1 2020 Apr 09, 2020	SELL	$6.28 - $14.57 $1,318 - $3,059	-210 Closed	0 $0
Q3 2019 Oct 11, 2019	BUY	$8.75 - $12.85 $1,137 - $1,670	130 Added 162.5%	210 $2,000
Q1 2019 Apr 05, 2019	SELL	$20.77 - $42.37 $1,453 - $2,965	-70 Reduced 46.67%	80 $3,000
Q4 2018 Feb 07, 2019	BUY	$20.07 - $46.7 $3,010 - $7,005	150 New	150 $3,000

100

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $135M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Larson Financial Group LLC with notifications on news.